With several antipsychotic and other psychotropic medications going off patent, you may be planning to conduct bioequivalence studies. CNS Network in Long Beach, CA, with Drs. David Walling, Mark Leibowitz and group, will provide rapid enrollment, quality data and extensive experience with these compounds. READ MORE.
We can offer full-service solutions.
We have ALWAYS met timelines for enrollment and cohorts on bioequivalence and early phase studies, including:
· Schizophrenia inpatient study phase IIa – randomized 98
· Schizophrenia inpatient study phase I – randomized 48 (4 cohorts) rescue site
· Schizophrenia bioequivalence study – randomized 30
Please be in touch for anything we can provide, generic or branded.